ENDRA Life Sciences (NDRA) Free Cash Flow Growth (1y) (2017 - 2026)
ENDRA Life Sciences (NDRA) Free Cash Flow Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -117.95% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 126.04% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 2.94% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 24.06% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 87.85% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -20.33% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 15.26% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 20.67% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -30.93% |
| 10 | ENDRA Life Sciences | 5.24 Mn | 4.89 Mn | - | 14.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.56% |
| Dec 31, 2025 | -6.33% |
| Sep 30, 2025 | 29.76% |
| Jun 30, 2025 | 46.26% |
| Mar 31, 2025 | 39.65% |
| Dec 31, 2024 | 30.52% |
| Sep 30, 2024 | 36.23% |
| Jun 30, 2024 | 8.65% |
| Mar 31, 2024 | 14.31% |
| Dec 31, 2023 | 30.24% |
| Sep 30, 2023 | 20.32% |
| Jun 30, 2023 | 33.17% |
| Mar 31, 2023 | 20.52% |
| Dec 31, 2022 | -17.89% |
| Sep 30, 2022 | -18.75% |
| Jun 30, 2022 | -21.27% |
| Mar 31, 2022 | -7.40% |
| Dec 31, 2021 | -24.08% |
| Sep 30, 2021 | -29.47% |
| Jun 30, 2021 | 18.90% |